Approved Drug Products with Therapeutic Equivalence Evaluations, 1999 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Approved Drug Products with Therapeutic Equivalence Evaluations, 1999 PDF full book. Access full book title Approved Drug Products with Therapeutic Equivalence Evaluations, 1999 by Barry Leonard. Download full books in PDF and EPUB format.
Author: Barry Leonard
Publisher: DIANE Publishing
ISBN: 0788186795
Category :
Languages : en
Pages : 892
Get Book Here
Book Description
Identifies drug products approved on the basis of safety & effectiveness by the FDA under the Federal Food, Drug, & Cosmetic Act. Drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation review) or pre-1938 drugs are not included in this publication. The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Contains therapeutic equivalence evaluations for approved multisource prescription drug products.
Author: Barry Leonard
Publisher: DIANE Publishing
ISBN: 0788186795
Category :
Languages : en
Pages : 892
Get Book Here
Book Description
Identifies drug products approved on the basis of safety & effectiveness by the FDA under the Federal Food, Drug, & Cosmetic Act. Drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation review) or pre-1938 drugs are not included in this publication. The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Contains therapeutic equivalence evaluations for approved multisource prescription drug products.
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1048
Get Book Here
Book Description
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899828
Category : Medical
Languages : en
Pages : 1299
Get Book Here
Book Description
FDA Orange Book 32nd Edition - 2012 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899801
Category : Medical
Languages : en
Pages : 1115
Get Book Here
Book Description
FDA Orange Book 30th Edition - 2010 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 718
Get Book Here
Book Description
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899798
Category : Medical
Languages : en
Pages : 1161
Get Book Here
Book Description
FDA Orange Book 29th Edition - 2009 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 193489981X
Category : Medical
Languages : en
Pages : 1253
Get Book Here
Book Description
FDA Orange Book 31st Edition - 2011 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: Barry Leonard
Publisher: DIANE Publishing
ISBN: 0788173243
Category :
Languages : en
Pages : 829
Get Book Here
Book Description
Identifies drug products approved on the basis of safety and effectiveness by the FDA under the Federal Food, Drug, and Cosmetic Act. Drugs on the market approved only on the basis of safety (covered by the ongoing Drug Efficacy Study Implementation review) or pre-1938 drugs are not included in this publication. The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Contains therapeutic equivalence evaluations for approved multisource prescription drug products.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309069866
Category : Medical
Languages : en
Pages : 280
Get Book Here
Book Description
The VA National Formulary generated controversy, which motivated congressional scrutiny and a directive to the VA to commission this report reviewing the experience with the National Formulary and formulary system. This Institute of Medicine committee was pleased to assist the Congress with this review, in part because the committee saw in the VHA example an opportunity to understand and anticipate problems that all publicly funded programs are likely to encounter in this new age of pharmaceuticals. The Congress asked the committee to review the restrictiveness of the National Formulary, its impact on the costs and quality of care in the VHA, and how it compared to formularies and drug management practices in the private sector and in other public programs, especially Medicaid. Detailed in the pages that follow, the committee's findings and conclusions on these questions are, the committee believes, highly instructive, though not always in the ways that we anticipated.
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 132
Get Book Here
Book Description
